Inspire Investing, LLC

13F Filings History

Latest 13F report
Q4 2024 - Jan 17, 2025
Value $
$894M
Signature - Title
Robert Netzly - President & CEO
Location
Meridian, ID
Summary
This page shows a list of all the recent 13F filings made by Inspire Investing, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Inspire Investing, LLC reported 824 stock holdings with total value $894M as of Q4 2024. Top holdings included USFR, ISRG, CAT, WWJD, and ANET.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 824 $894M +$99.3M -$155M -$55.7M USFR, ISRG, CAT, WWJD, ANET 13F-HR 1/17/2025, 04:13 PM
Q3 2024 827 $977M +$211M -$150M +$60.2M SMCI, IBD, CAT, USFR, ISRG 13F-HR 10/10/2024, 03:44 PM
Q2 2024 802 $868M +$93.5M -$171M -$77.6M IBD, USFR, CAT, ISRG, WWJD 13F-HR 8/12/2024, 05:01 PM
Q1 2024 792 $977M +$176M -$175M +$1.57M CAT, USFR, ISRG, IBD, PGR 13F-HR 5/7/2024, 04:51 PM
Q4 2023 785 $909M +$128M -$87.6M +$40.4M IBD, USFR, CAT, NOW, WWJD 13F-HR 2/12/2024, 02:43 PM
Q3 2023 791 $783M +$148M -$156M -$8.53M IBD, USFR, CAT, NOW, PLD 13F-HR 10/26/2023, 11:59 AM
Q2 2023 788 $827M +$130M -$120M +$10.2M IBD, USFR, ISRG, PLD, NOW 13F-HR 7/31/2023, 10:23 AM
Q1 2023 782 $786M +$116M -$142M -$25.9M USFR, IBD, PLD, ADI, NOW 13F-HR 4/24/2023, 10:24 AM
Q4 2022 743 $777M +$82.9M -$61.5M +$21.5M TFLO, USFR, IBD, WWJD, BLES 13F-HR 1/26/2023, 02:28 PM
Q3 2022 754 $708M +$138M -$155M -$17.5M TFLO, USFR, IBD, UUP, WWJD 13F-HR 11/7/2022, 05:01 PM
Q2 2022 762 $754M +$171M -$155M +$15.9M USFR, IBD, UUP, WWJD, BLES 13F-HR 8/10/2022, 12:37 PM
Q1 2022 788 $864M +$155M -$102M +$52.6M VGSH, IBD, PHYS, BLES, WWJD 13F-HR 4/21/2022, 10:10 AM
Q4 2021 786 $872M +$121M -$78.6M +$42.3M IBD, VGLT, ISRG, NOW, PLD Restatement 2/14/2022, 10:02 AM
Q3 2021 794 $791M +$422M -$359M +$63.5M IBD, VGLT, ISRG, NOW, BLES 13F-HR 11/9/2021, 02:02 PM
Q2 2021 593 $760M +$113M -$48.6M +$64.7M NVDA, IBD, BLES, VGLT, ISMD 13F-HR 8/10/2021, 04:58 PM
Q1 2021 597 $652M +$237M -$75.9M +$161M NVDA, IBD, VGIT, BLES, ISMD 13F-HR 4/30/2021, 12:07 PM
Q4 2020 622 $452M +$140M -$98.9M +$41.1M IBD, BLES, NVDA, ISMD, WWJD 13F-HR 2/12/2021, 02:47 PM
Q3 2020 432 $363M +$119M -$60.6M +$58.6M VGIT, IBD, BLES, NVDA, WWJD 13F-HR 11/16/2020, 04:27 PM
Q2 2020 485 $290M +$60.3M -$64.6M -$4.29M IBD, BLES, WWJD, ISMD, BIBL 13F-HR 8/12/2020, 03:46 PM
Q1 2020 739 $250M +$76.4M -$43.1M +$33.4M IBD, BLES, WWJD, ISMD, BIBL 13F-HR 5/8/2020, 04:44 PM
Q4 2019 351 $279M +$20.3M -$22.3M -$1.94M IBD, BLES, ISMD, BIBL, WWJD 13F-HR 1/24/2020, 12:28 PM
Q3 2019 375 $262M +$38.7M -$13.4M +$25.3M IBD, BLES, ISMD, BIBL, UNP 13F-HR 11/13/2019, 02:18 PM
Q2 2019 328 $238M +$30M -$10.2M +$19.8M IBD, BLES, ISMD, BIBL, UNP 13F-HR 7/16/2019, 01:32 PM
Q1 2019 297 $215M +$56M -$9.26M +$46.7M IBD, BLES, ISMD, BIBL, ABBV 13F-HR 5/16/2019, 07:42 AM
Q4 2018 242 $149M +$14M -$4.66M +$9.32M BLES, IBD, ISMD, BIBL, ABBV Restatement 2/21/2019, 06:01 PM
Q3 2018 237 $162M +$20.8M -$3.87M +$16.9M BLES, IBD, ISMD, BIBL, NVDA Restatement 2/21/2019, 05:59 PM
Q2 2018 220 $141M +$42.1M -$1.57M +$40.5M BLES, IBD, ISMD, BIBL, ABBV Restatement 2/21/2019, 05:59 PM
Q1 2018 199 $98.2M +$17.4M -$35.6M -$18.2M BLES, IBD, ISMD, BIBL, ITW Restatement 2/21/2019, 09:04 PM
Q4 2017 913 $118M $0 $0 BLES, IBD, ISMD, BIBL, NUE Restatement 2/21/2019, 05:49 PM